Brind.

Moderna and Merck are developing cancer vaccines in partnership, while Moderna is also seeking approval for its seasonal influenza vaccine.

Steady: 2 in the last 7 days Updated saturday

The latest in this situation

  1. Moderna's therapy combined with Merck's drug in an Australian-led clinical trial.
  2. Merck and Moderna funded an Australian-led clinical trial involving the University of Sydney.
  3. Moderna completed a successful Phase III mRNA vaccine trial with MSD and Geneva University Hospitals.

How it started

50 reports, 10 independent, last reported Sat 00:00. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 10 independent outlets

Moderna and Merck are developing cancer vaccines in partnership, while Moderna is also seeking approval for its seasonal influenza vaccine.

Who's involved

What this event is mainly about
ModernaMerckFDA

How it developed

Newest first. Tap a step to see who reported it.
  1. Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.Sub-event
  2. Moderna and Merck are developing a combination therapy using Keytruda.Sub-event
  3. Moderna and Merck are advancing personalized cancer treatment research and seeking regulatory approval for new drug trials.1 source
  4. Moderna partners with Merck on cancer vaccines and seeks FDA approval for flu vaccine.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
40 more outlets ran the same wire story